2007-07-04T00:00:00
Pharmaceutical company Janssen-Cilag has announced the authorisation of Invega (paliperidone), a new treatment for schizophrenia.
With a HSJ subscription you’ll unlock:
Part of HSJ Information Ltd. 5th Floor, Aldgate Tower, 2 Leman Street, London E1 8FA. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud